Helius Medical Technologies (NASDAQ: HSDT) reported Q2 EPS of ($0.38), $0.31 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $2.53 million versus the consensus estimate of $2.9 million.

For earnings history and earnings-related data on Helius Medical Technologies (HSDT) click here.